Clinical Trials Directory

Trials / Completed

CompletedNCT03451214

Evaluation of Zinc Intake on Essential Fatty Acid Metabolism

Effect of Zinc-Biofortified Wheat on Essential Fatty Acid Metabolism in Men

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
UCSF Benioff Children's Hospital Oakland · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the effect of different dietary zinc intakes on fatty acid metabolism and other zinc biomarkers

Detailed description

This research is a dietary intervention study designed to evaluate the effect of progressive changes in Zn intake on fatty acid metabolism and to correlate those changes with biomarkers of dyslipidemia and insulin resistance. The main objective is to validate plasma fatty acid metabolism as a biomarker of inadequate Zn intake in subjects consuming identical diets with specific Zn content. The relative sensitivity of some fatty acid enzyme activities will also be compared to the DNA strand breaks. In addition to the primary objectives, correlations in enzyme activity with changes in fat metabolism, namely circulating triglyceride and cholesterol, will be determined. This will enable the determination of the effect of a low Zn intake on various aspects of dyslipidemia. Similar correlational analyses will be performed with clinical measures of inflammation and insulin resistance.

Conditions

Interventions

TypeNameDescription
OTHERDiet Zinc4 mg zinc from zinc biofortified wheat, was added to a controlled diet; 25 mg supplemental zinc was given during the final recovery period

Timeline

Start date
2017-07-01
Primary completion
2018-06-30
Completion
2018-06-30
First posted
2018-03-01
Last updated
2018-08-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03451214. Inclusion in this directory is not an endorsement.